SCHEMBL8286384

SCHEMBL8286384

CCN(CC)C(=O)c1cc(C)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 5/20 0.42
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
GFER P55789 1/20 0.38
CSF1R P07333 1/20 0.36
HPGD P15428 4/20 0.36
CYP2C9 P11712 3/20 0.36
ALDH1A1 P00352 3/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 1/20 0.35
HTT P42858 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287518 0.87 PDE11A (0.44) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL5872175 0.87 PDE11A (0.47) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL8286401 0.86 PDE11A (0.42) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL8286396 0.86 PDE11A (0.44) PDE11AMAPK1GFERCSF1RHPGD
SCHEMBL5871541 0.86 PDE11A (0.46) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL5872166 0.85 PDE11A (0.42) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL8286372 0.85 CSF1R (0.47) PDE11AMAPTCSF1RHPGDALDH1A1
SCHEMBL8285174 0.85 PDE11A (0.43) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL8287397 0.85 PDE11A (0.46) PDE11AMAPTMAPK1GFERCSF1R
SCHEMBL8287393 0.85 PDE11A (0.46) PDE11AMAPTMAPK1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed